Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion: A long-term follow-up study

Digestive Surgery

Volumn 23, Issue 1-2, 2006, Pages 93-102

  Zheng, Gang Zhu ^a,b   Tang, Rui ^a   Yan, Min ^a   Chen, Jun ^a   Qiu, Meng Yang ^a   Li, Chen ^a   Xue, Xin Yao ^a   Zhang, Jun ^a   Hao, Ran Yin ^a   Yan, Zhen Lin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Intraoperative peritoneal hyperthermic chemotherapy; Peritoneal metastases; Prognosis; Stomach neoplasm

Indexed keywords

CISPLATIN; MITOMYCIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTRECTOMY; HEMODIALYSIS; HUMAN; HYPERTHERMIC THERAPY; INTRAOPERATIVE PERITONEAL HYPERTHERMIC CHEMOTHERAPY; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PERITONEUM; PERITONEUM METASTASIS; POSTOPERATIVE COMPLICATION; PROGNOSIS; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS;

CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; HYPERTHERMIA, INDUCED; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; PALLIATIVE CARE; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 33746794981     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093778     Document Type: Article

References (42)

1. Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruijn EA, Graves T, Mullins RE, Schlag P: Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16:83-97.
2. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS: Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-242.
3. Sugarbaker PH: Observations concerning cancer spread within the peritoneal cavity and concepts supporting and ordered pathophysiology; in Sugarbaker PH (ed): Peritoneal Carcinomatosis: Principles of Management. Boston, Kluwer Academic, 1996, pp 79-100.
4. Yonemura Y: Mechanisms of the information of peritoneal dissemination; in Yonemura Y (ed): Peritoneal Dissemination - Molecular Mechanisms and the Latest Therapy. Kanazawa, Maeda Shoten, 1998, pp 1-46.
5. Jacquet P, Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis; in Sugarbaker PH (ed): Peritoneal Carcinomatosis: Principles of Management. Boston, Kluwer Academic, 1996, pp 359-374.
6. Yonemura Y: Hyperthermo-chemotherapy for treatment of peritoneal carcinomatosis; in Yonemura Y (ed): Peritoneal Dissemination - Molecular Mechanisms and the Latest Therapy. Kanazawa, Maeda Shoten, 1998, pp 191-200.
7. Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, Sugiyama K, Kawamura T, Kinoshita K, Endou Y, Sasaki T: Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology 2001;48:1776-1782.
8. Fujimura T, Yonemura Y, Muraoka K, Takamura H, Hirono Y, Sahara H, Ninomiya I, Matsumoto H, Tsugawa K, Nishimura G: Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg 1994;18:150-155.
9. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T: Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999;85:529-534.
10. Hamazoe R, Maeta M, Kaibara N: Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 1994;73:2048-2052.
11. Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura K, Sawa T, Katayama K, Tanaka S, Hirono Y, Miwa K: Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 1995;19:450-454.
12. Hirose K, Katayama K, Iida A, Yamaguchi A, Nakagawara G, Umeda S, Kusaka Y: Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis. Oncology 1999;57:106-114.
13. Yonemura Y, Fujimura T, Nishimura G, Falla R, Sawa T, Katayama K, Tsugawa K, Fushida S, Miyazaki I, Tanaka M, Endou Y, Sasaki T: Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437-444.
14. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T, Isawa E, Sumida M, Ohkubo H: Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997;79:884-891.
15. Kuhn JA, McLoughlin JM, Harris DC, Talaasen LJ, Sutton SW, McCarty TM: Intraperitoneal hyperthermic chemotherapy: experience at Baylor University Medical Center. Proc Bayl Univ Med Cent 2002;15:359-362.
16. Sobin LH, Wittekind Ch (eds): UICC TNM Classification of Malignant Tumors, ed 5. New York, Wiley, 1997, pp 59-62.
17. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma (2nd English edition). Gastric Cancer 1998;1:10-24.
18. Sugarbaker PH, Stuart OA, Vidal-Jove J, Pessagno AM, DeBruijn EA: Pharmacokinetics of the peritoneal-plasma barrier after systemic mitomycin C administration. Cancer Treat Res 1996;82:41-52.
19. Jacquet P, Sugarbaker PH: Peritoneal-plasma barrier; in Sugarbaker PH (ed): Peritoneal Carcinomatosis: Principles of Management. Boston, Kluwer Academic, 1996, pp 53-56.
20. Cattel L, De Simone M, Passera R, Verlengo MC, Delprino L: Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis. Anticancer Res 2004;24:2041-2045.
21. Yonemura Y: Hyperthermo-chemotherapy for treatment of peritoneal carcinomatosis; in Yonemura Y (ed): Peritoneal Dissemination - Molecular Mechanisms and the Latest Therapy. Kanazawa, Maeda Shoten, 1998, pp 237-260.
22. Barlogie B, Corry PM, Drewinko B: In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammine platinum(II) and mitomycin C. Cancer Res 1980;40:1165-1168.
23. Choi EK, Park SR, Lee JH, Chung HS, Ahn HE, Rhee YH, Lim BU, Park HJ: Induction of apoptosis by carboplatin and hyperthermia alone or combined in WERI human retinoblastoma cells. Int J Hyperthermia 2003;19:431-443.
24. Ohtsubo T, Igawa H, Saito T, Matsumoto H, ParkH, Song CW, Kano E, Saito H: Enhancement of cell killing by induction of apoptosis after treatment with mild hyperthermia at 42°C and cisplatin. Radiat Res 2001;156:103-109.
25. Nakao K, Otsuki Y, Akao Y, Ito Y, Marukawa O, Tachibana S, Kawakami M, Sasaki S: The synergistic effects of hyperthermia and anticancer drugs on induction of apoptosis. Med Electron Microsc 2000;33:44-50.
26. Brundell S, Tucker K, Chatterton B, Hewett P: Influence of lavage timing on tumor cell burden during colonie resection. Dis Colon Rectum 2003;46:460-466.
27. Stewart JH 4th, Shen P, Levine EA: Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol 2005;12:765-777.
28. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A, Italian Research Group for Gastric Cancer: Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 2003;90:1113-1119.
29. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I: Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15:530-535.
30. Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T: Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232-237.
31. Sugarbaker PH: Review of a personal experience in the management of carcinomatosis and sarcomatosis. Jpn J Clin Oncol 2001;31:573-583.
32. Ceelen WP, Hesse U, de Hemptinne B, Pattyn P: Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000;87:1006-1015.
33. Hall JJ, Loggie BW, Shen P, Beamer S, Douglas Case L, McQuellon R, Geisinger KR, Levine EA: Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004;8:454-463.
34. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghausen SE, Dalton RR, Steves MA, Sugarbaker PH: Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996;77:2622-2629.
35. Gilly FN, Beaujard A, Glehen O, Grandclement E, Caillot JL, Francois Y, Sadeghi-Looyeh B, Gueugniaud PY, Garbit F, Benoit M, Bienvenu J, Vignal J: Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study. Anticancer Res 1999;19:2317-2321.
36. Schmidt U, Dahlke MH, Klempnauer J, Schlitt HJ, Piso P: Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2005;31:53-58.
37. Witkamp AJ, de Bree E, Kaag MM, Boot H, Beijnen JH, van Slooten GW, van Coevorden F, Zoetmulder FA: Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001;37:979-984.
38. Chen MY, Chiles C, Loggie BW, Choplin RH, Perini MA, Fleming RA: Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery. J Surg Oncol 1997;66:19-23.
39. Kunisaki C, Shimada H, Nomura M, Akiyama H, Takahashi M, Matsuda G: Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery 2002;131:521-528.
40. Yamaguchi A, Tsukioka Y, Fushida S, Kurosaka Y, Kanno M, Yonemura Y, Miwa K, Miyazaki I: Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers. Dis Colon Rectum 1992;35:964-968.
41. Gori J, Castano R, Toziano M, Habich D, Staringer J, De Quiros DG, Felci N: Intraperitoneal hyperthermic chemotherapy in ovarian cancer. Int J Gynecol Cancer 2005;15:233-239.
42. Kecmanovic DM, Pavlov MJ, Ceranic MS, Sepetkovski AV, Kovacevic PA, Stamenkovic AB: Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy. Eur J Surg Oncol 2005;31:147-152.